Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

686 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol.
Igarashi S, Manabe A, Ohara A, Kumagai M, Saito T, Okimoto Y, Kamijo T, Isoyama K, Kajiwara M, Sotomatsu M, Sugita K, Sugita K, Maeda M, Yabe H, Kinoshita A, Kaneko T, Hayashi Y, Ikuta K, Hanada R, Tsuchida M. Igarashi S, et al. J Clin Oncol. 2005 Sep 20;23(27):6489-98. doi: 10.1200/JCO.2005.01.982. J Clin Oncol. 2005. PMID: 16170158 Clinical Trial.
Prognostic factors of children and adolescents with T-cell acute lymphoblastic leukemia after allogeneic transplantation.
Ishida H, Kato M, Kawahara Y, Ishimaru S, Najima Y, Kako S, Sato M, Hiwatari M, Noguchi M, Kato K, Koh K, Okada K, Iwasaki F, Kobayashi R, Igarashi S, Saito S, Takahashi Y, Sato A, Tanaka J, Hashii Y, Atsuta Y, Sakaguchi H, Imamura T. Ishida H, et al. Among authors: igarashi s. Hematol Oncol. 2022 Aug;40(3):457-468. doi: 10.1002/hon.2980. Epub 2022 Mar 3. Hematol Oncol. 2022. PMID: 35212019
TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia.
Ueki H, Ogawa C, Goto H, Nishi M, Yamanaka J, Mochizuki S, Nishikawa T, Kumamoto T, Nishiuchi R, Kikuta A, Yamamoto S, Igarashi S, Sato A, Hori T, Saito AM, Watanabe T, Deguchi T, Manabe A, Horibe K, Toyoda H. Ueki H, et al. Among authors: igarashi s. Int J Hematol. 2024 Apr;119(4):450-458. doi: 10.1007/s12185-024-03710-6. Epub 2024 Jan 25. Int J Hematol. 2024. PMID: 38267673
Comparison of continuous and twice-daily infusions of cyclosporine A for graft-versus-host-disease prophylaxis in pediatric hematopoietic stem cell transplantation.
Umeda K, Adachi S, Tanaka S, Ogawa A, Hatakeyama N, Kudo K, Sakata N, Igarashi S, Ohshima K, Hyakuna N, Chin M, Goto H, Takahashi Y, Azuma E, Koh K, Sawada A, Kato K, Inoue M, Atsuta Y, Takami A, Murata M; GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation. Umeda K, et al. Among authors: igarashi s. Pediatr Blood Cancer. 2015 Feb;62(2):291-298. doi: 10.1002/pbc.25243. Epub 2014 Oct 12. Pediatr Blood Cancer. 2015. PMID: 25307105
Catheter-related bloodstream infection by Microbacterium paraoxydans in a pediatric patient with B-cell precursor acute lymphocytic leukemia: A case report and review of literature on Microbacterium bacteremia.
Amano J, Hase R, Otsuka Y, Tsuchimochi T, Noguchi Y, Igarashi S. Amano J, et al. Among authors: igarashi s. J Infect Chemother. 2019 Oct;25(10):806-810. doi: 10.1016/j.jiac.2019.03.013. Epub 2019 Apr 11. J Infect Chemother. 2019. PMID: 30982728 Review.
The impact of vitamin D on the onset and progress of Kawasaki disease.
Okazaki N, Ikeda H, Honda T, Tsuno K, Inoue F, Takahashi S, Sakurai A, Ueki H, Noguchi Y, Hamada H, Igarashi S. Okazaki N, et al. Among authors: igarashi s. Pediatr Int. 2022 Jan;64(1):e15191. doi: 10.1111/ped.15191. Pediatr Int. 2022. PMID: 35831250
686 results